Global Research Hotspots and Trends of Buyang Huanwu Decoction: A Visual Analysis of the Literature Based on CiteSpace

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Nov 13

PMID 39533635

Authors

Bowen Li

Maobo Du

Weijuan Gao

Affiliations

Soon will be listed here.

Abstract

Background: Buyang huanwu decoction (BYHWD) has shown significant clinical efficacy in the treatment of several diseases, particularly stroke. However, bibliometric research has not been comprehensive.

Methods: BYHWD articles were collected from literature databases published from January 1, 1915, to March 31, 2024, including the China National Knowledge Infrastructure, Weipu, Wanfang, Pubmed, Scopus, and Web of Science Core Collection. Knowledge network graphs of annual publication volume, authors, institutions, countries, keywords, and references were constructed.

Results: Nine thousand two hundred thirty-eight Chinese literature and 559 English articles published between 1915 and 2024 showed an overall upward trend. The countries, institutions, journals, and authors with the highest output were China, Hunan University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangxian Cai, and Changqing Deng, respectively. Research teams outside China were located at Daejeon University, Gachon University, Aga Khan University, Yale University, etc. The results of keyword co-occurrence and burst analysis included clinical applications, animal experiments, action mechanisms, clinical efficacy, and safety evaluations based on systematic reviews and meta-analyses. Literature co-citation analysis revealed that BYHWD was highly correlated with neuroprotection and reduction of cerebral ischemia/reperfusion injury.

Conclusion: Both Chinese and English literature have shown overall growth trend since 1984 and 1989, respectively. Clinical applications, pharmacological effects, mechanisms, active ingredients, evaluation of clinical efficacy and safety, modified BYHWD, methods, and biological techniques may be hotspots and focus of future research on BYHWD. Hotspot analytical methods and biological techniques include systematic reviews, meta-analyses, data mining, network pharmacology, and molecular docking. Future valuable research fields may include studies on neuroprotection, anti-inflammatory activity, ischemic stroke, bioactive compounds, and their underlying mechanisms.

References

She Y, Shao L, Zhang Y, Hao Y, Cai Y, Cheng Z . Neuroprotective effect of glycosides in Buyang Huanwu Decoction on pyroptosis following cerebral ischemia-reperfusion injury in rats. J Ethnopharmacol. 2019; 242:112051. DOI: 10.1016/j.jep.2019.112051. View

Li M, Li M, Lin Z, Zhuang Y, Wang H, Jia J . Buyang Huanwu Decoction promotes neurovascular remodeling by modulating astrocyte and microglia polarization in ischemic stroke rats. J Ethnopharmacol. 2023; 323:117620. DOI: 10.1016/j.jep.2023.117620. View

Wei R, Teng H, Yin B, Xu Y, Du Y, He F . A systematic review and meta-analysis of buyang huanwu decoction in animal model of focal cerebral ischemia. Evid Based Complement Alternat Med. 2013; 2013:138484. PMC: 3687599. DOI: 10.1155/2013/138484. View

Zhong D, Li L, Ma R, Deng Y . Systematic evaluation and re-evaluation of buyang huanwu decoction in treating ischemic stroke. Complement Ther Med. 2022; 70:102860. DOI: 10.1016/j.ctim.2022.102860. View

Zheng Y, Qi S, Wu F, Hu J, Zhong R, Hua C . Chinese Herbal Medicine in Treatment of Spinal Cord Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Chin Med. 2020; 48(7):1593-1616. DOI: 10.1142/S0192415X20500792. View

Wang R, Ma G, Yu S, Zhang M, Pu S . UPLC-MS based metabonomics revealed the protective effects of Buyang Huanwu decoction on ischemic stroke rats. Toxicol Res (Camb). 2024; 13(2):tfae052. PMC: 10982849. DOI: 10.1093/toxres/tfae052. View

Zhong D, Luo S, Zheng L, Zhang Y, Jin R . Epilepsy Occurrence and Circadian Rhythm: A Bibliometrics Study and Visualization Analysis via CiteSpace. Front Neurol. 2020; 11:984. PMC: 7674827. DOI: 10.3389/fneur.2020.00984. View

Chen X, Chen H, He Y, Fu S, Liu H, Wang Q . Proteomics-Guided Study on Buyang Huanwu Decoction for Its Neuroprotective and Neurogenic Mechanisms for Transient Ischemic Stroke: Involvements of EGFR/PI3K/Akt/Bad/14-3-3 and Jak2/Stat3/Cyclin D1 Signaling Cascades. Mol Neurobiol. 2020; 57(10):4305-4321. DOI: 10.1007/s12035-020-02016-y. View

Yan F, Ding H, Sun Z, Liu J, Li J, Zhou D . Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF. Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(6):1187-1203. DOI: 10.1007/s00210-023-02389-6. View

10.

He Z, Yang S, Tan Y, Liao Y, Song S . Efficacy and safety of Buyang Huanwu Decoction in patients with spinal cord injury: A meta-analysis of randomized controlled trials. Medicine (Baltimore). 2024; 103(16):e37865. PMC: 11030014. DOI: 10.1097/MD.0000000000037865. View

11.

Zhang X, Yang F, Zhang Y, Song X, Xue S, Chang Y . Modified Buyang Huanwu Decoction alleviates diabetic liver injury via inhibiting oxidative stress in db/db mice. Am J Transl Res. 2024; 16(1):39-50. PMC: 10839391. View

12.

Sabe M, Sulstarova A, Chen C, Hyde J, Poulet E, Aleman A . A century of research on neuromodulation interventions: A scientometric analysis of trends and knowledge maps. Neurosci Biobehav Rev. 2023; 152:105300. DOI: 10.1016/j.neubiorev.2023.105300. View

13.

Cheng M, Li T, Hu E, Yan Q, Li H, Wang Y . A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage. J Ethnopharmacol. 2023; 319(Pt 1):117123. DOI: 10.1016/j.jep.2023.117123. View

14.

Liao W, Wang P, He Y, Liu Z, Wang L . Investigation of the underlying mechanism of Buyang Huanwu decoction in ischemic stroke by integrating systems pharmacology-proteomics and in vivo experiments. Fitoterapia. 2024; 175:105935. DOI: 10.1016/j.fitote.2024.105935. View

15.

Wang J, Li J, Hu M . Mechanism analysis of Buyang Huanwu decoction in treating atherosclerosis based on network pharmacology and in vitro experiments. Chem Biol Drug Des. 2024; 103(1):e14447. DOI: 10.1111/cbdd.14447. View

16.

Pan R, Cai J, Zhan L, Guo Y, Huang R, Li X . Buyang Huanwu decoction facilitates neurorehabilitation through an improvement of synaptic plasticity in cerebral ischemic rats. BMC Complement Altern Med. 2017; 17(1):173. PMC: 5371213. DOI: 10.1186/s12906-017-1680-9. View

17.

do Carmo G, Felizardo L, de Castro Alcantara V, da Silva C, do Prado J . The impact of Jürgen Habermas's scientific production: a scientometric review. Scientometrics. 2023; 128(3):1853-1875. PMC: 9803888. DOI: 10.1007/s11192-022-04625-x. View

18.

Fu X, Sun Z, Long Q, Tan W, Li Y, Wu L . [Mechanism of Buyang Huanwu Decoction glycosides against atherosclerotic inflammation through NF-κB signaling pathway]. Zhongguo Zhong Yao Za Zhi. 2023; 48(1):202-210. DOI: 10.19540/j.cnki.cjcmm.20220905.703. View

19.

Zhu J, Bao X, Zheng Q, Tong Q, Zhu P, Zhuang Z . Buyang Huanwu Decoction Exerts Cardioprotective Effects through Targeting Angiogenesis via Caveolin-1/VEGF Signaling Pathway in Mice with Acute Myocardial Infarction. Oxid Med Cell Longev. 2019; 2019:4275984. PMC: 6501136. DOI: 10.1155/2019/4275984. View

20.

Zhao L, Wang J, Jin G, Zhao Y, Zhang H . Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats--time window and mechanism. J Ethnopharmacol. 2012; 140(2):339-44. DOI: 10.1016/j.jep.2012.01.026. View